Latest news with #Paysign
Yahoo
10-07-2025
- Business
- Yahoo
Up 113% in a Year, How Much Higher Can Paysign Stock Go?
Paysign (PAYS) hit a new 52-week high on July 9. The stock has strong technical momentum and a 100% 'Buy' signal via Barchart. Shares are up more than 110% over the past year. Analysts covering PAYS stock have a consensus 'Strong Buy' rating. Valued at just $460 million, Paysign (PAYS) is a provider of prepaid card programs and processing services for corporate, consumer, and government applications. I found today's Chart of the Day by using Barchart's powerful screening functions. I sorted for stocks with the highest technical buy signals, superior current momentum in both strength and direction, and a Trend Seeker 'buy' signal. I then used Barchart's Flipcharts feature to review the charts for consistent price appreciation. PAYS checks those boxes. Since the Trend Seeker signaled a buy on April 30, the stock has gained 254.17%. PAYS Price vs. Daily Moving Averages: Editor's Note: The technical indicators below are updated live during the session every 20 minutes and can therefore change each day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the website when you read this report. These technical indicators form the Barchart Opinion on a particular stock. PaySign shares hit a new 52-week high on July 9, touching $8.57 in intraday trading. As of this writing, they had retreated slightly and were trading 2.57% below the new high. PAYS has an 100% technical 'Buy' signal. The stock recently traded at $8.57, above its 50-day moving average of $4.76. Paysign has a Weighted Alpha of +103.66. The stock has gained 113% over the past year. PAYS has its Trend Seeker 'Buy' signal intact. Paysign is trading above its 20, 50 and 100-day moving averages. The stock made 16 new highs and gained 67.3% in the last month. Relative Strength Index is at 87.59%. The technical support level is $8.13. $460 million market cap. Trailing price-earnings ratio of 72.82. Revenue is projected to grow 28.71% this year and another 19.36% next year. Earnings are estimated to increase 121.43% this year and increase an additional 54.84% next year. I don't buy stocks because everyone else is buying, but I do realize that if major firms and investors are dumping a stock, it's hard to make money swimming against the tide. It looks like Wall Street analysts are bullish, but some major advisory sites think the stock may be priced too high for further price appreciation. The Wall Street analysts tracked by Barchart issued five 'Strong Buy' opinions on the stock. Value Line gives the stock its average rating. CFRA's MarketScope rates the stock a 'Buy.' MorningStar thinks the stock is 6% undervalued. 5,400 investors monitor the stock on Seeking Alpha, which rates the stock a 'Hold.' Paysign currently has momentum and is hitting new highs. I caution that PAYS is volatile and speculative — use strict risk management and stop-loss strategies. Today's Chart of the Day was written by Jim Van Meerten. Read previous editions of the daily newsletter here. Additional disclosure: The Barchart of the Day highlights stocks that are experiencing exceptional current price appreciation. They are not intended to be buy recommendations as these stocks are extremely volatile and speculative. Should you decide to add one of these stocks to your investment portfolio it is highly suggested you follow a predetermined diversification and moving stop loss discipline that is consistent with your personal investment risk tolerance. On the date of publication, Jim Van Meerten did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Business Wire
08-07-2025
- Business
- Business Wire
Paysign to Host Second Quarter 2025 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, financial technology products and integrated payment processing, will discuss second quarter 2025 earnings at 5:00 p.m. Eastern time on Tuesday, August 5, 2025. Participant details are as follows: U.S. dial-in: 877.407.2988 International dial-in: +1.201.389.0923 Webcast: Click Here Replay: Dial-in: 877.660.6853 or +1.201.612.7415 Conference ID: 13754588 The replay will be available until November 5, 2025. To register as a financial professional in order to ask questions during the call, please email ir@ no later than 5:00 p.m. Eastern time on Friday, August 1, 2025. About Paysign Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, financial technology products and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality and retail. Built on the foundation of a reliable payments platform, Paysign's end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses, per diem, reimbursements, rebates and countless other exchanges of value. Paysign's solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit Forward-Looking Statements Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.
Yahoo
14-06-2025
- Business
- Yahoo
Paysign price target raised to $8 from $7 at DA Davidson
DA Davidson analyst Peter Heckmann raised the firm's price target on Paysign (PAYS) to $8 from $7 and keeps a Buy rating on the shares. Last week, Paysign announced the company had been awarded 132 established plasma donation centers through an expansion of a relationship with a major plasma collection company, and the firm believes this will increase the company's total plasma locations to 613 centers, a 27% increase over the 484 locations served at the end of Q1, the analyst tells investors in a research note. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on PAYS: Disclaimer & DisclosureReport an Issue PaySign's Strong Growth Potential and Strategic Positioning in Healthcare: A Buy Rating by Gary Prestopino Paysign participates in a conference call with DA Davidson PaySign's Strong Growth Potential and Strategic Positioning Earns Buy Rating from Analyst Paysign awarded 132 plasma donation centers Paysign price target raised to $6-$7 range from $5 at Barrington
Business Wire
11-06-2025
- Business
- Business Wire
Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced the successful transition of 123 out of 132 newly awarded plasma donation centers. The remaining nine centers are on track to go live in the third quarter of 2025. We delivered a seamless experience for center staff, leadership teams and donors—without disruption—setting a new benchmark for speed and precision in the industry. Share The onboarding of 123 centers was completed in just one week – significantly ahead of schedule – demonstrating Paysign's operational agility, platform scalability and executional discipline. 'Successfully transitioning this volume of centers in a single week is a testament to the strength of our platform, the rigor of our processes and the exceptional capabilities of our team,' said Mark Newcomer, President and CEO of Paysign. 'We delivered a seamless experience for center staff, leadership teams and donors—without disruption—setting a new benchmark for speed and precision in the industry. The addition of these centers represents a pivotal return to revenue growth for this business unit. This, combined with the continuing exceptional growth of our patient affordability business, gives us great confidence in Paysign's forward momentum.' This achievement reinforces Paysign's strategic value to plasma collection organizations seeking reliable, scalable and compliant payment solutions. It also underscores the company's continued momentum in the healthcare financial services sector and its ability to capitalize on growth opportunities with speed and efficiency. Forward-Looking Statements Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise. About Paysign Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, financial technology products and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality, and retail. Built on the foundation of a reliable payments platform, Paysign's end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. Paysign's solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit
Yahoo
11-06-2025
- Business
- Yahoo
Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers
HENDERSON, Nev., June 11, 2025--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced the successful transition of 123 out of 132 newly awarded plasma donation centers. The remaining nine centers are on track to go live in the third quarter of 2025. The onboarding of 123 centers was completed in just one week – significantly ahead of schedule – demonstrating Paysign's operational agility, platform scalability and executional discipline. "Successfully transitioning this volume of centers in a single week is a testament to the strength of our platform, the rigor of our processes and the exceptional capabilities of our team," said Mark Newcomer, President and CEO of Paysign. "We delivered a seamless experience for center staff, leadership teams and donors—without disruption—setting a new benchmark for speed and precision in the industry. The addition of these centers represents a pivotal return to revenue growth for this business unit. This, combined with the continuing exceptional growth of our patient affordability business, gives us great confidence in Paysign's forward momentum." This achievement reinforces Paysign's strategic value to plasma collection organizations seeking reliable, scalable and compliant payment solutions. It also underscores the company's continued momentum in the healthcare financial services sector and its ability to capitalize on growth opportunities with speed and efficiency. Forward-Looking Statements Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise. About Paysign Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, financial technology products and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality, and retail. Built on the foundation of a reliable payments platform, Paysign's end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. Paysign's solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit View source version on Contacts Investor Relations ir@ Media Relations Alicia Ches888.522.4850pr@
